West Pharmaceutical Services Accrued salaries, wages and benefits decreased by 46.6% to $72.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $67.80M to $72.60M. Over 5 years (FY 2020 to FY 2025), Accrued salaries, wages and benefits shows an upward trend with a 5.1% CAGR.
Significant increases may reflect accrued bonuses or changes in headcount, while decreases may indicate the timing of payroll or bonus payouts.
The liability for earned but unpaid employee compensation, including wages, bonuses, and benefits as of the balance shee...
Generally consistent across companies with similar labor-intensive business models.
current_liabilities_accrued_salaries_wages_and_benefits_current| Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $116.30M | $77.50M | $78.80M | $76.80M | $65.70M | $85.40M | $90.50M | $105.90M | $66.50M | $82.90M | $79.60M | $73.50M | $67.80M | $93.40M | $111.80M | $135.90M | $72.60M |
| QoQ Change | — | -33.4% | +1.7% | -2.5% | -14.5% | +30.0% | +6.0% | +17.0% | -37.2% | +24.7% | -4.0% | -7.7% | -7.8% | +37.8% | +19.7% | +21.6% | -46.6% |
| YoY Change | — | — | — | -34.0% | -15.2% | +8.4% | — | +37.9% | +1.2% | -2.9% | -12.0% | -30.6% | +2.0% | +12.7% | +40.5% | +84.9% | +7.1% |